Lv41
510 积分 2024-06-13 加入
GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology
10天前
已完结
AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys
10天前
已完结
Therapeutic potentials of glucose-dependent insulinotropic polypeptide (GIP) in T2DM: Past, present, and future
10天前
已完结
Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity
10天前
已完结
Safety of native glucose-dependent insulinotropic polypeptide in humans
10天前
已完结
The unexpected role of GIP in transforming obesity treatment
10天前
已完结
The effects of GIP, GLP-1 and GLP-2 on markers of bone turnover: a review of the gut-bone axis
10天前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
19天前
已完结
Impact of baseline characteristics on the efficacy of once‐weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China
19天前
已完结
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial
20天前
已完结
皖公网安备34019202002308
